REVA Medical, out of San Diego, California, has released its Fantom Encore bioresorbable scaffold. The implant is made with the company’s own Tyrocore polymer that is absorbed by the body over a period of time, eventually disappearing while native tissue takes over. The process helps to make sure that the lumen stays open while cells grow and rebuild the native structure of the vessel.
This is the company’s third generation of bioresorbable scaffolds, and it is CE Marked in Europe and available in a number of countries. The new device has thinner struts compared to other similar coronary artery bioresorbable devices. It is visible under fluoroscopy thanks to its radiopaque material.
“My experience with Fantom Encore is that it is easy to use due to its thinner strut profile, x-ray visibility, and strength,” said Dr. Matthias Lutz at the Universitätsklinikum Schleswig-Holstein in Kiel, Germany. “With these device improvements and the investment in the FANTOM Post Market Trial, REVA is partnering with physicians to advance the field of bioresorbable scaffolds.”
Product page: Fantom Encore…
Via: REVA…